NBIX
NBIX
US64125C1099
Neurocrine Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.860.500.000 2.355.300.000
21.4%
Cost of Revenue 52.100.000 34.000.000
53.2%
Gross Profit 2.808.400.000 2.321.300.000
21.0%
2.171.900.000 1.738.300.000
24.9%
Operating Income 636.500.000 583.000.000
9.2%
Pretax Income 705.400.000 486.000.000
45.1%
Net Income Common Stockholders 478.600.000 341.300.000
40.2%
-- --
--
-- --
--
ende